EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Update in the management of gastroenteropancreatic neuroendocrine tumors

Andrew J H Sedlack iD, Diana Grace Varghese, Amirkia Naimian, Pouria Yazdian Anari, Lisa Bodei, Julie Hallet iD, Rachel P Riechelmann, Thor Halfdanarson, Jaume Capdevilla, Jaydira Del Rivero iD

Cancer · 15.09.2024 · 130 (18) · 3090-3105

DOI: 10.1002/cncr.35463 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer, online erschienen am 16.07.2024. Verfasst von Andrew J H Sedlack und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Pancreatic Neoplasms, Stomach Neoplasms, Intestinal Neoplasms. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroendocrine neoplasms are a diverse group of neoplasms that can occur in various areas throughout the body. Well‐differentiated neuroendocrine tumors (NETs) most often arise in the gastrointestinal tract, termed gastroenteropancreatic neuroendocrine tumors (GEP‐NETs). Although GEP‐NETs are still uncommon, their incidence and prevalence have been steadily increasing over the past decades. The primary treatment for GEP‐NETs is surgery, which offers the best chance for a cure. However, because GEP‐NETs are often slow‐growing and do not cause symptoms until they have spread widely, curative surgery is not always an option. Significant advances have been made in systemic and locoregional treatment options in recent years, including peptide‐receptor radionuclide therapy with α and β emitters, somatostatin analogs, chemotherapy, and targeted molecular therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsPancreatic NeoplasmsStomach NeoplasmsIntestinal NeoplasmsHumansSomatostatinMolecular Targeted Therapy

Stichwörter der Autor:innen

delayed diagnosisgastrointestinal neoplasmsmolecularly targeted therapyneuroendocrine carcinomaneuroendocrine tumorspancreatic neoplasmsstomach neoplasms

Substanzen

Somatostatin

Autor:innen und Institutionen

  • Medical Scientist Training Program, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Developmental Therapeutics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
  • Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA.
  • Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Odette Cancer Centre, Sunnybrook Health Sciences Centre, East York, Ontario, Canada.
  • Departamento de Oncologia Clínica, AC Camargo Cancer Center, Sao Paolo, Brazil.

ORCID-Profile: Andrew J H Sedlack, Julie Hallet, Jaydira Del Rivero

Förderung

  • NCI NIH HHS

Zitieren

APA

Sedlack, A. J. H., Varghese, D. G., Naimian, A., Yazdian Anari, P., Bodei, L., Hallet, J., Riechelmann, R. P., Halfdanarson, T., Capdevilla, J., & Del Rivero, J. (2024). Update in the management of gastroenteropancreatic neuroendocrine tumors. Cancer, 130(18), 3090-3105. https://doi.org/10.1002/cncr.35463

Vancouver

Sedlack AJH, Varghese DG, Naimian A, Yazdian Anari P, Bodei L, Hallet J, et al. Update in the management of gastroenteropancreatic neuroendocrine tumors. Cancer. 2024;130(18):3090-3105. doi:10.1002/cncr.35463

BibTeX
@article{Sedlack2024,
  author = {Sedlack, Andrew J H and Varghese, Diana Grace and Naimian, Amirkia and Yazdian Anari, Pouria and Bodei, Lisa and Hallet, Julie and Riechelmann, Rachel P and Halfdanarson, Thor and Capdevilla, Jaume and Del Rivero, Jaydira},
  title = {Update in the management of gastroenteropancreatic neuroendocrine tumors},
  journal = {Cancer},
  year = {2024},
  volume = {130},
  number = {18},
  pages = {3090--3105},
  doi = {10.1002/cncr.35463}
}
Kostenlos starten →